Clinical trial · Interventional
Fluoroscopic &Ultrasonographic Guidance of Superior Hypogastric Plexus Neurolysis in Intractable Pelvic Pain
The Role of Double Modality " Fluoroscopic &Ultrasonographic " Guidance of Superior Hypogastric Plexus Neurolysis in Treating Intractable Pelvic Cancer Pain: a Comparative Study.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
fluoroscopic group \& includes 30 patients where SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.the double modality group \& includes 30 patients where SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Intractable Pelvic Cancer Pain | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| double modality (ultrasound and fluroscopic) guided block | Procedure | — | UNRESOLVED |
| fluroscopic guided block | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- fluroscopic guided block
- interventionNames
- Procedure: fluroscopic guided block
- type
- EXPERIMENTAL
- label
- double modality guided block
- interventionNames
- Procedure: double modality (ultrasound and fluroscopic) guided block
Primary outcomes (1)
- measure
- pain relief will be assessed by VAS
- timeFrame
- 12 weeks
- description
- pain relief will be assessed by VAS (visual Analogue score) which is 100 mscale with left (0) end means no pain \& right (10) end means the worst possible pain
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 years. * Intractable pelvic cancer pain (VAS \> 40 mm) * Pain is refractory to pharmacotherapy (both opioids and adjuvant therapy) or opioids' side effects are not tolerated. Exclusion criteria * Local or systemic sepsis. * Uncorrectable coagulopathy. * Neuropsychiatric illness. * History of drug abuse. * Pregnant or lactating patients. * Distorted local anatomy. * Patients who are known to be allergic to the used medications. * Cardiovascular or respiratory instability.
References
Publications (0)
Data not yet available